Antenatal steroid therapy: Have we undervalued the risks?

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 19, Issue 5, 2006, Pages 265-269

  Cavalieri, Ralph L ^a   Cohen, Wayne R ^a  

^a JAMAICA HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Antenatal corticosteroid therapy; Brain development; Preterm delivery

Indexed keywords

CORTICOSTEROID; STEROID;

BRAIN DEVELOPMENT; BRAIN GROWTH; DRUG SAFETY; FETUS LUNG MATURATION; HUMAN; LONG TERM EXPOSURE; MATERNAL CARE; NERVE CELL DIFFERENTIATION; NONHUMAN; PREGNANCY; PREMATURE LABOR; PRENATAL EXPOSURE; PRENATAL PERIOD; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK FACTOR;

ANIMALS; BETAMETHASONE; BRAIN; DEXAMETHASONE; FEMALE; FETAL ORGAN MATURITY; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; LUNG; NEURONS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK ASSESSMENT; RISK FACTORS;

EID: 33745081870     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050600676075     Document Type: Review

References (46)

1. Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995;173:254-262.
2. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515-525.
3. Collaborative Group on Antenatal Steroid Therapy. Effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome. Am J Obstet Gynecol 1981;141:276-287.
4. Crowley PA. Prophylactic corticosteroids for preterm birth. The Cochrane database of systematic reviews, 10/27/1999, The Cochrane Library 2:2002.
5. NIH Consensus Development Panel. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995;173:413-418.
6. MacArthur BA, Howie RN, Dezoete JA, Elkins J. School progress and cognitive development of 6-year-old children whose mothers were treated antenatally with betamethasone. Pediatrics 1982;70:99-105.
7. Smolders-de Haas H, Neuvel J, Schmand B, Treffers PE, Hoeks J. Physical development and medical history of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome: A 10 to 12 year follow-up. Pediatrics 1990;86:65-70.
8. Planer BC, Ballard RA, Ballard PL, Coburn CE, Boardman CR, Cnaan A, Morgan MA, Parer J. Antenatal corticosteroids (ANCS) use in preterm labor in the USA (abstract). Pediatr Res 1996;39:110A.
9. National Institutes of Health Consensus Development Conference Statement. Effect of corticosteroids for fetal maturation on perinatal outcomes, February 28-March 24, 1994. Am J Obstet Gynecol 1995;173:246-252.
10. ACOG Committee Opinion. Antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol 2002;99:871-873.
11. Garite TJ, Rumney PJ, Briggs GG, Harding JA, Nageotte MP, Towers CV, Freeman RK. A randomized, placebo-controlled trial of betamethasone for the prevention of respiratory distress syndrome at 24 to 28 weeks' gestation. Am J Obstet Gynecol 1992;166:646-651.
12. NIH Consensus Development Conference Statement on Repeat Courses of Antenatal Corticosteroids, August 17-18, 2000.
13. Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, Yurman S, Dolfin T, Kogan A, Dollberg S, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 2000;83:F177-181.
14. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shankaran S, Donovan EF, Oh W, Bauer CR, Saha S, et al. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. N Engl J Med 2001;344:95-101.
15. Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, Tsai CH. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 2004;350:1304-1313.
16. Johnson JWC, Mitzner W, Beck JC, London WT, Sly DL, Lee PA, Khouzami VA, Cavalieri RL. Long-term effects of betamethasone on fetal development. Am J Obstet Gynecol 1981;141:1053-1064.
17. Uno H, Lohmiller L, Thieme C, Kemnitz JW, Engle MJ, Roecker EB, Farrell PM. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Dev Brain Res 1990;53:157-167.
18. Uno H, Eisele S, Sakai A, Shelton S, Baker E, DeJesus O, Holden J. Neurotoxicity of glucocorticoids in the primate brain. Horm Behav 1994;28:336-348.
19. Jobe AH, Wada N, Berry LM, Ikegami M, Ervin MG. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol 1998;178:880-885.
20. Huang WL, Beazley LD, Quinlivan JA, Evans SF, Newnham JP, Dunlop SA. Effect of corticosteroids on brain growth in fetal sheep. Obstet Gynecol 1999;94:213-218.
21. Huang WL, Harper CG, Evans SF, Newnham JP, Dunlop SA. Repeated prenatal corticosteroid administration delays astrocyte and capillary tight junction maturation in fetal sheep. Int J Dev Neurosci 2001;19:487-493.
22. Antonow-Schlorke I, Schwab M, Li C, Nathanielsz PW. Glucocorticoid exposure at the dose used clinically alters cytoskeletal proteins and presynaptic terminals in the fetal baboon brain. J Physiol 2003;547:117-123.
23. Pavlik A, Benesova O. Perinatal treatment with glucocorticoids and the risk of maldevelopment of the brain. Neuropharmacology 1989;28:89-97.
24. Carlos RQ, Seidler FJ, Slotkin TA. Fetal dexamethasone exposure alters macromolecular characteristics of rat brain development: A critical period for regionally selective alterations? Teratology 1992;46:45-59.
25. Brabham T, Phelka A, Zimmer C, Nash A, Lopez JF, Vazquez DM. Effects of prenatal dexamethasone on spatial learning and response to stress is influenced by maternal factors. Am J Physiol Regul Integr Comp Physiol 2000;279:R1899-1909.
26. Bloom SL, Sheffield JS, Mclntire DD, Leveno KJ. Antenatal dexamethasone and decreased birth weight. Obstet Gynecol 2001;97:485-490.
27. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP. Repeated antenatal corticosteroids: Size at birth and subsequent development. Am J Obstet Gynecol 1999;180:114-121.
28. Abbasi S, Hirsch D, Davis J, Tolosa J, Stouffer N, Debbs R, Gerdes JS. Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome. Am J Obstet Gynecol 2000;182:1243-1249.
29. Dirnberger DR, Yoder BA, Gordon MC. Single versus repeated-course antenatal corticosteroids: Outcomes in singleton and multiple-gestation pregnancies. Am J Perinatol 2001;18:267-277.
30. Modi N, Lewis H, Al-Naqeeb N, Ajayi-Obe M, Dore CJ, Rutherford M. The effects of repeated antenatal glucocorticoid therapy on the developing brain. Pediatr Res 2001;50:581-585.
31. French NP, Hagan R, Evans SF, Mullan A, Newnham JP. Repeated antenatal corticosteroids: Effects on cerebral palsy and childhood behavior. Am J Obstet Gynecol 2004;190:588-595.
32. Esplin MS, Fausett MB, Smith S, Oshiro BT, Porter TF, Branch DW, Varner MW. Multiple courses of antenatal steroids are associated with a delay in long-term psychomotor development in children with birth weights less than or equal to 1500 grams. Am J Obstet Gynecol 2000;182:S24.
33. Ulloa L, Montejo de Garcini E, Gomez-Ramos P, Moran MA, Avila J. Microtubule-associated protein MAP1B showing a fetal phosphorylation pattern is present in sites of neurofibrillary degeneration in brains of Alzheimer's disease patients. Brain Res Mol Brain Res 1994;26:113-122.
34. Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: An overview: Structure, regulation, and clinical implications. Neurobiol Dis 2004;16:1-13.
35. Dysken M, Patlak CS, Dobben GD, Pettigrew KD, Bartko JJ, Burns EM, Davis J, Regier DA. Rapid dynamic CT scanning to distinguish schizophrenic from normal subjects. Psychiatry Res 1987;20:165-175.
36. Sapolsky RM. Why stress is bad for your brain. Science 1996;273:749-750.
37. Haynes LE, Griffiths MR, Hyde RE, Barber DJ, Mitchell IJ. Dexamethasone induces limited apoptosis and extensive sublethal damage to specific subregions of the striatum and hippocampus: Implications for mood disorders. Neuroscience 2001;104:57-69.
38. Hynd GW, Semrud-Clikeman M, Lorys AR, Novey ES, Eliopulos D, Lyytinen H. Corpus callosum morphology in attention deficit-hyperactivity disorder: Morphometric analysis of MRI. J Learn Disabil 1991;24:141-146.
39. Abernethy LJ, Palaniappan M, Cooke RWI. Quantitative magnetic resonance imaging of the brain in survivors of very low birth weight. Arch Dis Child 2002;87:279-283.
40. Newnham JP. Is prenatal glucocorticoid administration another origin of adult disease? Clin Exp Pharmacol Physiol 2001;28:957-961.
41. Crowley PA. Antenatal corticosteroid therapy: A meta-analysis of randomized trials, 1972 to 1994. Am J Obstet Gynecol 1995;173:322-335.
42. Egger M, Smith GD. Meta-analysis bias in location and selection of studies. BMJ 1998;316:61-66.
43. Vohr BR, Wright LL, Poole WK, McDonald SA. Neurodevelopmental outcomes of extremely low birth weight infants < 32 weeks' gestation between 1993 and 1998. Pediatrics 2005;116:635-643.
44. Tran U, Gray PH, O'Callaghan MJ. Neonatal antecedents for cerebral palsy in extremely preterm babies and interaction with maternal factors. Early Hum Dev 2005;81:555-561.
45. Griffith HR, Pyzalski RW, Seidenberg M, Hermann BP. Memory relationships between MRI volumes and resting PET metabolism of medial temporal lobe structures. Epilepsy Behav 2004;5:669-676.
46. Dalziel SR, Walker NK, Parag V, Mantell C, Rea HH, Rodgers A, Harding JE. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomized controlled trial. Lancet 2005;365:1856-1862.